Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026.
- Largest single sale: $25.3M (218,535 shares) of Abbott Laboratories on Aug 25, 2026. Filing
- Last sale before this period: Feb 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Abbott Laboratories (ABT) | Chairman and CEO, Director | Jul 3, 2014 | Aug 27, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 25, 2026, Abbott Laboratories: sold 398,832 shares for $46.2M, no plan disclosed; 398,832 shares acquired by exercising options. 1 filing: 1
- Feb 27, 2026, Abbott Laboratories: 30,308 shares withheld by the company for taxes. 1 filing: 1
- Feb 24, 2026, Abbott Laboratories: 83,464 shares awarded. 1 filing: 1
- Jan 23, 2026, Abbott Laboratories: bought 18,800 shares for $2.0M (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.